Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Jeffrey Scott DePue
Introduction
Jeffrey Scott DePue is a notable inventor based in Windham, NH (US). He has made significant contributions to the field of antiviral medications, particularly through his work on viral inhibitors. With a total of 4 patents to his name, DePue continues to push the boundaries of medical innovation.
Latest Patents
One of DePue's latest patents focuses on viral inhibitors, specifically the synthesis of maribavir and its intermediates. Maribavir is a benzimidazole riboside that serves as an orally available antiviral medication against cytomegalovirus (CMV). The patent discloses compositions comprising maribavir and methods for providing these compositions, highlighting the importance of his work in combating viral infections.
Career Highlights
DePue is currently associated with Takeda Pharmaceutical Company Limited, where he applies his expertise in pharmaceutical research and development. His work has been instrumental in advancing antiviral therapies, showcasing his commitment to improving public health through innovative solutions.
Collaborations
Throughout his career, DePue has collaborated with esteemed colleagues such as Helge Alfred Reisch and Suresh Kumar Tipparaju. These partnerships have further enriched his research and contributed to the success of his inventions.
Conclusion
Jeffrey Scott DePue's contributions to the field of antiviral medications exemplify the impact of innovation in healthcare. His work continues to pave the way for new treatments that can significantly improve patient outcomes.